Skip to content

Central Venous Pressure and Right Atrial Pressure Measurements in Supine, Semi-recumbent and Trendelenburg Position

Central Venous Pressure and Right Atrial Pressure Measurements in Supine, Semi-recumbent and Trendelenburg Position

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06705374
Enrollment
16
Registered
2024-11-26
Start date
2023-11-15
Completion date
2024-12-30
Last updated
2025-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Brief summary

Intensive care is directed towards patients with severe illness or risk of serious outcomes following, for example, surgery. Central venous pressure (CVP) is an important part of the hemodynamic assessment of patients in surgery and the intensive care unit (ICU). CVP is normally measured via a central venous catheter (CVC) inserted through the subclavian or internal jugular vein, with the tip placed at the junction to the right atrium. A pressure tubing is connected to one of the branches of the CVC and then connected to a pressure sensor that sends a digital signal to the monitoring screen where CVP can be read in mmHg. To accurately read CVP, the pressure sensor must be positioned at the level of the right atrium. Different external reference points are used nationally and internationally to locate the correct height for the pressure sensor. This study aims to investigate the most commonly used external reference points for CVP measurement in various body positions compared to CVP measured via a solid state pressure catheter in the right atrium (RAP).

Detailed description

A Millar Mikro-Cath solid state pressure catheter is inserted through one of the medial lines of the CVC and guided in position by the pressure curve and verified in position by ultrasound. CVP is compared to RAP in supine, semi-recumbent, Trendelenburg and lateral position. CVP, RAP and arterial pressure is recorded in each session with Biopac Acqnowledge. In each body position PEEP is raised 5 cmH20 and then lowered 5 cmH20. Ventilator settings, capillary refill time, perfusion index are collected in each setting and before and after PEEP adjustments.

Interventions

None listed

Sponsors

Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill patients in mechanical ventilation with an arterial line and a four or five lumen CVC.

Exclusion criteria

* under 18 years of age * in a dynamic phase of their illness i.e. ongoing treatment of severe circulatory or respiratory failure * positive end-expiratory pressure (PEEP) \>14 cmH20 or intolerance to change of body position.

Design outcomes

Primary

MeasureTime frameDescription
Difference in mmHg between RAP and CVP in semi-recumbent position3 minutes after body position changeDifference in mmHg between RAP (Millar Micro-Cath) and CVP.
Difference in mmHg between RAP and CVP in right lateral position3 minutes after body position changeDifference in mmHg between RAP (Millar Micro-Cath) and CVP.
Difference in mmHg between RAP and CVP in left lateral position3 minutes after body position changeDifference in mmHg between RAP (Millar Micro-Cath) and CVP.
Difference in mmHg between Right atrial pressure (RAP) and Central venous pressure (CVP) in supine position3 minutes after body position changeDifference in mmHg between RAP (Millar Micro-Cath) and CVP.
Difference in mmHg between RAP and CVP in Trendelenburg position3 minutes after body position changeDifference in mmHg between RAP (Millar Micro-Cath) and CVP.

Secondary

MeasureTime frameDescription
Change in hemodynamic parameters after PEEP change1 minutes after PEEP changeChange in RAP (mmHg)
Change in hemodynamic parameters after body position change3 minutes after body position changeChange in CVP (mmHg)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 14, 2026